Trial Profile
A trial to determine the efficacy and safety of topical bevacizumab treatment in patients with ocular surface squamous neoplasia
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Jun 2016
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary)
- Indications Eye disorders
- Focus Therapeutic Use
- 08 Jun 2016 New trial record